Can Finerenone Alter Glomerular Disease Trajectory?

• by Kathryn Wighton

• June 5, 2026

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

• by Andrea Surnit

• June 5, 2026

• 7 min

Abnormal active myocardial relaxation by dipyridamole stress test in suspected early-stage heart failure with preserved ejection fraction: a retrospective exploratory analysis

• by Gabriella Locorotondo, Monica Filice, Francesca Augusta Gabrielli, Giacomo Moretti, Laura Manfredonia, Antonella Lombardo, Gaetano Antonio Lanza, Leonarda Galiuto

• May 28, 2026

Biologics Commonly Used in Cutaneous Crohn's Disease

Retrospective multicenter cohort highlights genital-predominant presentation patterns and frequent combination therapy use in cutaneous Crohn's disease.

• by Andrea Surnit

• May 27, 2026

• 3 min